| View |
|
DRP-5833-01
|
Tranexamic Acid
|
None
|
500mg
|
Capsule
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
15 November 2021
|
15 March 2025
|
| View |
|
DRP-10762
|
Oxytocin
|
Oxycare
|
10 IU/mL
|
Solution for I.V. Injection (I.M./I.V.
Infusion)
|
-
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
-
|
16 November 2021
|
16 November 2026
|
| View |
|
DR-XY47551
|
Cefuroxime (As Sodium)
|
Globalfur
|
750 mg
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
-
|
19 November 2021
|
19 November 2026
|
| View |
|
DR-XY47550
|
Cefuroxime (As Sodium)
|
Globalfur
|
1.5 g
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
-
|
19 November 2021
|
19 November 2026
|
| View |
|
DRP-4696-12
|
Piperacillin (As Sodium) + Tazobactam (As Sodium)
|
Lifetazil
|
4 g/500 mg
|
Powder For Injection (IV)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Zeiss Pharmaceuticals Pvt. Limited
|
India
|
Automatic Renewal
|
11 October 2022
|
05 September 2028
|
| View |
|
DRP-6118
|
Rabeprazole Sodium
|
None
|
20mg
|
Enteric-Coated Tablet
|
-
|
Daewon Pharm.Co., Ltd.
|
Korea
|
-
|
17 November 2021
|
27 April 2025
|
| View |
|
DRP-5827
|
Dimenhydrinate
|
None
|
50mg
|
Tablet
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
15 November 2021
|
16 May 2025
|
| View |
|
DR-XY40560
|
Cefixime (As Trihydrate)
|
Fixim
|
200 mg
|
Film-Coated Tablet
|
-
|
Lark Laboratories (India) Ltd.
|
India
|
-
|
10 November 2021
|
27 January 2025
|
| View |
|
DR-XY45949
|
Ascorbiv Acid
|
Vista C Supreme
|
444.50 mg Capsule (equivalent to 500 mg sodium ascorbate)
|
Capsule
|
-
|
Doctors Pharmaceuticals, Inc.
|
Philippines
|
-
|
15 November 2021
|
10 July 2025
|
| View |
|
DR-XY40925
|
Ceftazidime
|
Argan
|
1 g
|
Powder For Injection (Im/Iv)
|
-
|
Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd.
|
China
|
-
|
10 November 2021
|
22 June 2025
|
| View |
|
DRP-5504
|
Thiamazole
|
Unbranded
|
5mg
|
Tablet
|
Antithyroidism (Thioamides)
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
12 October 2024
|
24 February 2030
|
| View |
|
DRP-5258-01
|
Amoxicillin (As Trihydrate)
|
None
|
250mg/5mL
|
Powder For Suspension
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
15 November 2021
|
23 February 2025
|
| View |
|
DRP-2171
|
Tobramycin + Dexamethasone
|
Tobrason
|
3 mg/1 mg per mL
|
Ophthalmic Suspension (Eye Drops)
|
-
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
10 November 2021
|
14 May 2025
|
| View |
|
DRP-2449
|
Ofloxacin
|
Oflobiz
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution
|
-
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
10 November 2021
|
14 May 2025
|
| View |
|
DRP-2448
|
Ofloxacin
|
Oflobiz
|
3 mg/mL (0.3% w/v)
|
Otic Solution
|
-
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
10 November 2021
|
14 May 2025
|
| View |
|
DR-XY44621
|
Diosmin + Hesperidin
|
Hespadin
|
450 mg /50 mg
|
Film Coated Tablet
|
Vasoprotective
|
Pell Tech Health Care Pvt. Ltd.
|
India
|
-
|
10 November 2021
|
08 June 2025
|
| View |
|
DR-XY47545
|
Moxifloxacin (As Hydrochloride)
|
Avelox
|
400 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Bayer Healthcare Manufacturing S.R.L.
|
Italy
|
Initial (Correction)
|
13 March 2024
|
18 November 2026
|
| View |
|
DRP-872
|
Losartan Potassium + Hydrochlorothiazide
|
Nipartan -H
|
50 mg + 12.5 mg
|
Tablet
|
-
|
Micro Labs Limited
|
India
|
-
|
10 November 2021
|
04 April 2025
|
| View |
|
DR-XY31042
|
Hyoscine-N-Butylbromide
|
Fucon
|
10 mg
|
Tablet
|
-
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
-
|
10 November 2021
|
19 May 2025
|
| View |
|
DR-XY44697
|
Bisoprolol Fumarate
|
Ancor-5
|
5 mg
|
Film-Coated Tablet
|
-
|
Aristopharma Ltd.
|
Bangladesh
|
-
|
10 November 2021
|
03 July 2025
|